- Home
- PHI vs INSP Comparison
PHI vs INSP Comparison
Compare PHI & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHI
- INSP
- Stock Information
- Founded
- PHI 1928
- INSP 2007
- Country
- PHI Philippines
- INSP United States
- Employees
- PHI N/A
- INSP N/A
- Industry
- PHI Telecommunications Equipment
- INSP Medical/Dental Instruments
- Sector
- PHI Telecommunications
- INSP Health Care
- Exchange
- PHI Nasdaq
- INSP Nasdaq
- Market Cap
- PHI 4.8B
- INSP 4.4B
- IPO Year
- PHI 1953
- INSP 2018
- Fundamental
- Price
- PHI $23.04
- INSP $150.21
- Analyst Decision
- PHI
- INSP Buy
- Analyst Count
- PHI 0
- INSP 10
- Target Price
- PHI N/A
- INSP $222.20
- AVG Volume (30 Days)
- PHI 104.3K
- INSP 473.9K
- Earning Date
- PHI 05-08-2025
- INSP 05-05-2025
- Dividend Yield
- PHI 6.38%
- INSP N/A
- EPS Growth
- PHI 21.44
- INSP N/A
- EPS
- PHI 2.57
- INSP 1.75
- Revenue
- PHI $3,733,350,583.00
- INSP $802,804,000.00
- Revenue This Year
- PHI $5.38
- INSP $20.65
- Revenue Next Year
- PHI $2.89
- INSP $17.49
- P/E Ratio
- PHI $8.84
- INSP $85.83
- Revenue Growth
- PHI 2.79
- INSP 28.49
- 52 Week Low
- PHI $20.29
- INSP $123.00
- 52 Week High
- PHI $29.05
- INSP $257.40
- Technical
- Relative Strength Index (RSI)
- PHI 55.07
- INSP 44.54
- Support Level
- PHI $20.29
- INSP $137.97
- Resistance Level
- PHI $23.72
- INSP $152.25
- Average True Range (ATR)
- PHI 0.95
- INSP 10.34
- MACD
- PHI 0.19
- INSP 0.57
- Stochastic Oscillator
- PHI 80.17
- INSP 55.92
About PHI PLDT Inc. Sponsored ADR
PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.